SHAREHOLDER ACTION NOTICE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Athira Pharma, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

THE ANGEL–(BUSINESS WIRE) – Schall Law Firm, a national shareholder rights law firm, announces the filing of a class action lawsuit against Athira Pharma, Inc. (“Athira” or “the Company”) (NASDAQ: ATHA) for violations of federal securities laws.

Investors who acquired the Company’s shares in accordance with the Company’s initial public offering in September 2020 (the “IPO”) or between September 18, 2020 and June 17, 2021, both days inclusive (the “Class Period”) and / or due to this, are requested to contact the law firm before August 20, 2021.

If you are a shareholder who has suffered a loss, click here to participate.

We also encourage you to contact Brian Schall of the Schall law firm, 2049 Century Park East, Suite 2460, Los Angeles, CA 90067, at 310-301-3335 to discuss your rights free of charge. You can also contact us on the firm’s website at or by email at [email protected]

In this case, the class has not yet been certified and you will not be represented by a lawyer until certified. If you do nothing, you can remain an absent class member.

According to the lawsuit, the company provided false and misleading information to the market. The research conducted by Athira CEO and President Leen Kawas was tainted by scientific misconduct. Kawas is believed to have been involved in the manipulation of key data in research through the manipulation of Western blot images. The tainted research was critical to the company’s efforts to develop treatments for Alzheimer’s. The company’s research and development efforts were based on invalid data. Because of these facts, the company’s public statements were false and materially misleading throughout the course period. When the market learned the truth about Athira, investors suffered damage.

Join the case to make up for your losses.

The law firm Schall represents investors worldwide and specializes in securities class actions and shareholder disputes.

This press release may be viewed as a solicitation in some jurisdictions under applicable law and ethical rules.

Comments are closed.